RadNet operates one of the largest networks of freestanding outpatient diagnostic imaging centers in the United States. It provides MRI, CT, PET, mammography and other radiology services to patients referred by physicians and health systems, typically outside the hospital setting. Scale in multi-modality outpatient imaging, dense regional clusters and growing use of AI-assisted interpretation are central to how it competes. Customers are mainly individuals covered by insurers and referring clinical practices rather than inpatient hospital departments.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 471.4 | — | -37.9 | — |
| Q2 2025 | 498.2 | — | 14.4 | — |
| Q3 2025 | 522.9 | — | 5.4 | — |
| Q4 2025 | 547.7 | — | -0.6 | — |
| Q1 2026 | 575.6 | 22.1% | -33.5 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Dianthus Therapeutics, Inc. (DNTH), Casella Waste Systems, Inc. (CWST), VSE Corporation (VSEC), Xenon Pharmaceuticals Inc. (XENE), PTC Therapeutics, Inc. (PTCT), ExlService Holdings, Inc. (EXLS)